Pictured is Allison Conti, Founder and CEO of Watkins-Conti Products, while she was initiating clinical trials at Stanford University Medical Center. Image provided by Vince David Photos
Clinical innovations today are driven by science and technology. Pharmaceutical companies globally have invested billions of dollars into the creation and invention of medications and medical devices that would prevent or cure health challenges in the world. Allison Watkins-Conti is a problem solver and innovator whose decision to venture into the women’s healthcare realm was inspired by her desire to help and improve lives. Through her company, Watkins-Conti Products Inc.; she is leading the charge towards creating a lasting medical solution for pelvic health problems that women face in today’s environment.
According to statistics, an estimated one in three women suffers from involuntary urine leakage, a problem Ms. Conti herself has experience with. Through the company she founded, Watkins-Conti Products, Inc.; this mom-turned-CEO, inventor, serial entrepreneur, business leader, and advisor is dedicated to developing affordable, effective solutions to millions of women around the world. The aim of the company is the creation and manufacturing of direct to consumer devices that are accessible, affordable and effective in solving the major health challenges that millions of women currently face. WCP has been described as an innovative and technologically savvy company and is on the verge of delivering its flagship product YoniFit to market in a truly disruptive manner, once the FDA approval process is complete.
Currently, the company is conducting a randomized, comparator-controlled, single-blinded, multicenter study that will evaluate the efficacy and safety of Yōni.Fit in women with stress urinary incontinence. The study, which began enrolling participants in July, is being led by Erik Sokol, MD, associate professor of obstetrics and gynecology at the Stanford University School of Medicine. This multi-site trial is also being conducted at Thomas Jefferson University in Philadelphia. “We are excited to reach this pivotal stage in the development of Yoni.Fit® and address this debilitating problem that affects millions of women worldwide with an easy-to-use, everyday solution,” Founder Allison Conti said. “Our hope is that it will improve millions of women’s lives. I’m so thankful to collaborate with these amazing institutions, and the many participants in our clinical trials around the country, who will be among the first to experience the benefits of this device that has changed my own life.”
You can learn more at www.LeakyLady.com
Watkins-Conti Products is leading the change for innovative ways of fixing health issues without patients having to break the bank. At the core of the company’s production policies are quality, safety, affordability, and accessibility. The CEO has been recognized for her contributions to innovation in Women’s Healthcare. For instance, she has gained the attention of Dr. Donnica Moore, a highly regarded physician, educator, and media commentator who has had over 850 television interviews including “The Dr. Oz Show”, “Good Morning America Health”, and “The Oprah Winfrey Show.” Dr. Donnica has more than 180 published articles in medical journals and consumer magazines and over 30 awards for her achievements in medicine and business. She was honored as one of the “Top 25 Women Entrepreneurs” by Leading Women Entrepreneurs in 2017 and she earned her medical degree from the State University of New York School of Medicine at Buffalo. Her work has been featured in Business Week, The New York Times, and The Wall Street Journal. Dr. Donnica Moore said:
“Yoni.Fit will be a great solution for the tens of millions of women not getting therapy for SUI as it allows for at-home use which gives women more privacy about an issue that has such a negative stigma. Additionally, doctors look for treatments like Yoni.Fit which have the lowest risk of side effects and the highest potential reward. Women shouldn’t need a diaper bag after their children turn three years old, for themselves! This new therapy offers relief and hope to women who suffer from SUI.”
Allison has patents all over the world and was recently named among the top 20 under 40 in Business Times Magazine. She has also been recognized as part of the 20th-Century Women in Innovation and made the list of the Top Ten Inspirational Women by Disrupt Magazine. In addition, Allison was most recently conferred on the list of Top 50 women leaders making a difference.
The project has yielded an immense amount of support, including almost $5 million in funding, bringing on the first venture capital partner, Cortado Ventures. “Watkins-Conti’s Yoni.Fit® is uniquely poised to address a common yet serious issue that a sizable portion of our female population faces,” Cortado Ventures Managing Partner Nathaniel Harding said. “The team brings the expertise and drive to successfully carry their invention through clinical trials and to a household brand name.”
Watkins-Conti Products Inc. has been recognized for its contribution to healthcare and scientific advancement in the field. Some of these recognition includes the “Most Promising New Venture” award in the Oklahoma Venture Forum for 2021 as well as being named in the Top Ten Nephrology and Urology Companies by MedTech Outlook, among several others. Learn more about WCP flagship products by visiting its website or following the Instagram page.
